About this trial
The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.
Eligibility criteria
Qualifiers
infants born before 31+6 weeks gestation
signed consent for participation in the project and consent for the processing of personal data
diagnosed with bronchopulmonary dysplasia
type of pulmonary ventilation - low-flow nasal cannulas
Disqualifiers
unsigned consent for participation in the project and/or consent for the processing of personal data
child diagnosed with conditions other than bronchopulmonary dysplasia (BPD) at high risk of long-term hypoxia - selected chronic cardiovascular, neurological, and muscular diseases, e.g., significant congenital heart defects, congenital central nervous system developmental disorders, genetic diseases associated with the risk of hypoventilation, central apneas, severe early obstructive sleep apnea
other chronic respiratory diseases besides BPD - e.g., cystic fibrosis, chronic aspiration
insufficient therapy through long-term home oxygen therapy
Trial design
Treatments tested in this trial
- Pulse oximeter
Treatment groups
Sponsors and collaborators
Institute of Health Information and Statistics of the Czech Republic
Lead sponsor
České Budějovice Hospital
Collaborator
University Hospital Olomouc
Collaborator
Institute for the Care of Mother and Child, Prague, Czech Republic
Collaborator
General University Hospital, Prague
Collaborator